4765-63-3

Basic information

• Product Name: 1,4,6-triaminopyrimidine-2(1H)-thione
• Synonyms: 1,4,6-Triaminopyrimidine-2(1H)-thione; 2(1H)-pyrimidinethione, 1,4,6-triamino-
• CAS NO: 4765-63-3
• Molecular Formula: C₄H₇N₅S
• Molecular Weight: 157.1969
• Mol File: 4765-63-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 336°C at 760 mmHg
• Flash Point: 157°C
• Density: 1.89g/cm³
• Vapor Pressure: 0.000116mmHg at 25°C
• Refractive Index: 1.899
• CAS DataBase Reference: 1,4,6-triaminopyrimidine-2(1H)-thione(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4,6-triaminopyrimidine-2(1H)-thione(4765-63-3)
• EPA Substance Registry System: 1,4,6-triaminopyrimidine-2(1H)-thione(4765-63-3)

Safety Data

• Hazardous Substances Data: 4765-63-3(Hazardous Substances Data)

Usage

Synonyms

2,4,6-Triamino pyrimidine

Type of compound

Heterocyclic organic compound

Composition

Contains nitrogen and sulfur atoms

Applications

a. Synthesis of pharmaceuticals
b. Synthesis of agrochemicals
c. Potential use as a corrosion inhibitor
d. Potential use as an antiviral agent

Significance

Versatile building block in medicinal and agricultural chemistry

Additional potential

Development of novel materials and as a precursor for the synthesis of other valuable compounds

Upstream product

• 79-19-6 thiosemicarbazide 
• 109-77-3 malononitrile 

Downstream Products

• 129147-73-5 7-Amino-2-phenyl<1,2,4>triazolo<1,5-c>pyrimidin-5(6H)-thione 
• 119293-98-0 2-Methyl-3-oxo(4H)-6-amino-8-thioxopyrimido<3,4-b>-1,2,4-triazine 

Relevant articles and documents

Novel cephalosporin compounds and processes for preparation thereof

-

Cephalosporin compounds

The present invention relates to new cephalosporin compounds of the formula(I), pharmaceutically acceptable non-toxic salts thereof, and physiologically hydrolyzable esters and solvates thereof, which have potent and broad antibacterial activities STR1 wherein R1 is a C1?4 alkyl, C3?4 alkenyl, C3?4 alkynyl group, or --C(Ra)(Rb)CO2 H1 wherein Ra and Rb are the same or different, and each is a hydrogen atom or a C1?4 alkyl group, or Ra and Rb form a C3?7 cycloalkyl group with the carbon atom to which they are linked; R2 is a C1?4 alkyl, C3?4 alkenyl or C3?4 cycloalkyl group, a substituted or unsubstituted amino group, or a substituted or unsubstituted phenyl group; R3 is hydrogen or a C1?4 alkyl group; and Q is N or CH. The invention further relates to a process for preparing said compounds, and to pharamaceutical compositions containing said compounds.